https://news.medxy.ai/zh/%e9%ab%98%e8%a1%80%e5%8e%8b%e9%ab%98%e5%8d%b1%e6%82%a3%e8%80%85%e6%9c%af%e4%b8%ad%e8%a1%80%e5%8e%8b%e5%a6%82%e4%bd%95%e4%bc%98%e5%8c%96%ef%bc%9f-histap%e8%af%95%e9%aa%8c%e5%b8%a6/Medxy AIzh2026-07-09T14:58:06-07:00高血压高危患者术中血压如何优化？——HISTAP试验带来的启示 https://news.medxy.ai/ja/intraoperative-blood-pressure-in-hypertensive-patients/Medxy AIja2026-07-09T14:57:50-07:00高血圧ハイリスク患者の術中血圧管理を最適化する：HISTAP試験から得られた知見 https://news.medxy.ai/vi/intraoperative-blood-pressure-in-hypertensive-high-risk-patients/Medxy AIvi2026-07-09T14:57:32-07:00Tối ưu hóa huyết áp trong mổ ở bệnh nhân tăng huyết áp nguy cơ cao: Những phát hiện từ thử nghiệm HISTAP https://news.medxy.ai/optimizing-intraoperative-blood-pressure-in-hypertensive-high-risk-patients/Medxy AIen2026-07-09T14:56:54-07:00Optimizing Intraoperative Blood Pressure in Hypertensive High-Risk Patients: Insights from the HISTAP Trial https://news.medxy.ai/zh/ai-driven-real-time-monitoring-of-inspiratory-effort-and-ventilator-synchrony/Medxy AIzh2026-07-09T14:46:10-07:00AI驱动的实时监测：让机械通气中的呼吸努力与人机同步性可视化 https://news.medxy.ai/ja/ai-driven-inspiratory-effort-and-patient-ventilator-synchrony/Medxy AIja2026-07-09T14:45:48-07:00機械換気を革新するAI：吸気努力と患者―人工呼吸器同調性のリアルタイム監視 https://news.medxy.ai/vi/ai-driven-real-time-monitoring-of-inspiratory-effort/Medxy AIvi2026-07-09T14:45:22-07:00Cách mạng hóa thông khí cơ học: Theo dõi thời gian thực nỗ lực hít vào và sự đồng bộ bệnh nhân–máy thở bằng AI https://news.medxy.ai/ai-driven-real-time-monitoring-of-inspiratory-effort-and-patient-ventilator-synchrony/Medxy AIen2026-07-09T14:44:31-07:00Revolutionizing Mechanical Ventilation: AI-Driven Real-Time Monitoring of Inspiratory Effort and Patient-Ventilator Synchrony https://news.medxy.ai/zh/prolonged-emergency-increased-mortality/Medxy AIzh2026-07-09T14:39:03-07:00急诊滞留越久，30天死亡风险越高：英格兰全国观察性研究揭示新证据 https://news.medxy.ai/ja/prolonged-emergency-department-increased-mortality/Medxy AIja2026-07-09T14:38:38-07:00救急外来滞在の長期化は30日死亡増加と関連：英国全国観察研究が示す新知見 https://news.medxy.ai/vi/prolonged-emergency-department-stay-linked-to-increased-mortality/Medxy AIvi2026-07-09T14:38:04-07:00Lưu trú kéo dài tại khoa cấp cứu liên quan đến tăng tử vong 30 ngày: Gợi ý từ một nghiên cứu quan sát toàn quốc ở Anh https://news.medxy.ai/prolonged-emergency-department-stay-linked-to-increased-30-day-mortality/Medxy AIen2026-07-09T14:37:14-07:00Prolonged Emergency Department Stay Linked to Increased 30-Day Mortality: Insights from a National Observational Study in England https://news.medxy.ai/zh/poct-testing-on-respiratory-outbreak/Medxy AIzh2026-07-09T14:07:46-07:00养老院床旁多重PCR检测：对呼吸道暴发管理与急诊转运的影响 https://news.medxy.ai/ja/point-of-care-multiplex-pcr-testing-on-respiratory-outbreak/Medxy AIja2026-07-09T14:07:28-07:00介護施設における現場即時マルチプレックスPCR検査：呼吸器流行管理と救急搬送への影響 https://news.medxy.ai/vi/point-of-care-multiplex-pcr-testing-in-nursing-homes-impact-on-respiratory-outbreak/Medxy AIvi2026-07-09T14:07:06-07:00Xét nghiệm PCR đa tác nhân tại điểm chăm sóc ở viện dưỡng lão: Tác động đối với quản lý bùng phát hô hấp và chuyển cấp cứu https://news.medxy.ai/point-of-care-multiplex-pcr-testing-in-nursing-homes-impact-on-respiratory-outbreak-management-and-emergency-transfers/Medxy AIen2026-07-09T14:06:15-07:00Point-of-Care Multiplex PCR Testing in Nursing Homes: Impact on Respiratory Outbreak Management and Emergency Transfers https://news.medxy.ai/zh/chronic-sleep-restriction-on-body-weight-and-composition/Medxy AIzh2026-07-09T13:28:25-07:00慢性轻度睡眠限制对体重与体成分的影响：来自合并随机试验的证据 https://news.medxy.ai/ja/chronic-mild-sleep-restriction-on-body-weight-and-composition/Medxy AIja2026-07-09T13:28:00-07:00慢性的な軽度睡眠制限が体重と体組成に及ぼす影響：ランダム化試験の統合解析から得られた知見 https://news.medxy.ai/vi/impact-of-chronic-mild-sleep-restriction-on-body-weight-and-composition/Medxy AIvi2026-07-09T13:27:29-07:00Ngủ ngắn kéo dài ảnh hưởng thế nào đến cân nặng và thành phần cơ thể? Góc nhìn từ các thử nghiệm ngẫu nhiên gộp https://news.medxy.ai/impact-of-chronic-mild-sleep-restriction-on-body-weight-and-composition-insights-from-pooled-randomized-trials/Medxy AIen2026-07-09T13:26:33-07:00Impact of Chronic Mild Sleep Restriction on Body Weight and Composition: Insights from Pooled Randomized Trials https://news.medxy.ai/vi/non-relapse-mortality-in-haploidentical-hematopoietic-cell-transplantation/Medxy AIvi2026-07-09T12:45:50-07:00CHIME: Mô hình eplet HLA mới dự đoán tử vong không do tái phát trong ghép tế bào tạo máu nửa hòa hợp https://news.medxy.ai/chime-a-novel-hla-eplet-model-predicting-non-relapse-mortality-in-haploidentical-hematopoietic-cell-transplantation/Medxy AIen2026-07-09T12:44:30-07:00CHIME: A Novel HLA Eplet Model Predicting Non-Relapse Mortality in Haploidentical Hematopoietic Cell Transplantation https://news.medxy.ai/ja/decitabine-cedazuridine-plus-venetoclax-for-acute-myeloid-leukemia/Medxy AIja2026-07-09T12:40:43-07:00新規診断急性骨髄性白血病の高齢・適応外患者における経口デシタビン/セダズリジン＋ベネトクラクスの長期成績 https://news.medxy.ai/vi/oral-decitabine-cedazuridine-plus-venetoclax-in-patients-with-newly-diagnosed-acute-myeloid-leukemia/Medxy AIvi2026-07-09T12:40:18-07:00Kết quả dài hạn của decitabine/cedazuridine đường uống phối hợp venetoclax ở bệnh nhân cao tuổi hoặc không phù hợp điều trị tích cực mắc bạch cầu cấp dòng tủy mới chẩn đoán https://news.medxy.ai/long-term-outcomes-of-oral-decitabine-cedazuridine-plus-venetoclax-in-older-or-unfit-patients-with-newly-diagnosed-acute-myeloid-leukemia/Medxy AIen2026-07-09T12:38:54-07:00Long-term Outcomes of Oral Decitabine/Cedazuridine Plus Venetoclax in Older or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia https://news.medxy.ai/zh/tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm/Medxy AIzh2026-07-09T11:19:23-07:00解码母细胞性浆细胞样树突状细胞肿瘤对 Tagraxofusp 的耐药机制：TXNRD1 与 TET2 突变的作用 https://news.medxy.ai/ja/resistance-to-tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm/Medxy AIja2026-07-09T11:18:57-07:00BPDCNにおけるタグラキソフスプ耐性の解明：TXNRD1とTET2変異の関与 https://news.medxy.ai/vi/decoding-resistance-to-tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm/Medxy AIvi2026-07-09T11:18:28-07:00Giải mã tình trạng kháng Tagraxofusp trong u tế bào tua tương bào dạng nguyên bào: vai trò của TXNRD1 và các đột biến TET2 https://news.medxy.ai/decoding-resistance-to-tagraxofusp-in-blastic-plasmacytoid-dendritic-cell-neoplasm-the-role-of-txnrd1-and-tet2-mutations/Medxy AIen2026-07-09T11:17:35-07:00Decoding Resistance to Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm: The Role of TXNRD1 and TET2 Mutations https://news.medxy.ai/ja/non-pf4-heparin-binding-platelet-activating-antibodies-in-heparin-induced-thrombocytopenia/Medxy AIja2026-07-09T11:04:14-07:00ヘパリン起因性血小板減少症におけるPF4／ヘパリン非結合性・血小板活性化抗体の解明――診断と病態形成への示唆 https://news.medxy.ai/vi/unveiling-non-pf4-heparin-binding-platelet-activating-antibodies-in-heparin-induced-thrombocytopenia/Medxy AIvi2026-07-09T11:03:49-07:00Kháng thể hoạt hóa tiểu cầu không gắn PF4/heparin trong giảm tiểu cầu do heparin: Ý nghĩa đối với chẩn đoán và bệnh sinh https://news.medxy.ai/unveiling-non-pf4-heparin-binding-platelet-activating-antibodies-in-heparin-induced-thrombocytopenia-implications-for-diagnosis-and-pathogenesis/Medxy AIen2026-07-09T11:03:05-07:00Unveiling Non-PF4/Heparin-Binding, Platelet-Activating Antibodies in Heparin-Induced Thrombocytopenia: Implications for Diagnosis and Pathogenesis https://news.medxy.ai/zh/radiation-exposure-in-bronchoscopy-fluoroscopy-versus-robotic-techniques/Medxy AIzh2026-07-09T10:08:25-07:00支气管镜检查中的辐射暴露：常规透视与机器人技术的比较 https://news.medxy.ai/ja/radiation-exposure-in-bronchoscopy-conventional-fluoroscopy-vs-robotic-techniques/Medxy AIja2026-07-09T10:08:10-07:00気管支鏡検査における放射線被曝：従来の透視法とロボット技術の比較 https://news.medxy.ai/vi/radiation-exposure-in-bronchoscopy/Medxy AIvi2026-07-09T10:07:49-07:00Phơi Nhiễm Bức Xạ Trong Nội Soi Phế Quản: Huỳnh Quang Quy Ước So Với Kỹ Thuật Robot https://news.medxy.ai/radiation-exposure-in-bronchoscopy-conventional-fluoroscopy-versus-robotic-techniques/Medxy AIen2026-07-09T10:07:02-07:00Radiation Exposure in Bronchoscopy: Conventional Fluoroscopy versus Robotic Techniques https://news.medxy.ai/zh/lung-function-decline-and-mortality-in-fibrotic-interstitial-lung-disease/Medxy AIzh2026-07-09T10:03:19-07:00破解纤维化间质性肺病疗效评估难题：肺功能下降与死亡风险的联合模型 https://news.medxy.ai/ja/enhancing-treatment-evaluation-in-fid/Medxy AIja2026-07-09T10:03:03-07:00線維性間質性肺疾患における治療評価を高める：肺機能低下と死亡を統合したジョイントモデル https://news.medxy.ai/vi/enhancing-treatment-evaluation-in-fibrotic-interstitial-lung-disease/Medxy AIvi2026-07-09T10:02:44-07:00Nâng cao đánh giá điều trị trong bệnh phổi kẽ xơ hóa: Mô hình kết hợp giữa suy giảm chức năng phổi và tử vong https://news.medxy.ai/enhancing-treatment-evaluation-in-fibrotic-interstitial-lung-disease-a-joint-model-of-lung-function-decline-and-mortality/Medxy AIen2026-07-09T10:01:57-07:00Enhancing Treatment Evaluation in Fibrotic Interstitial Lung Disease: A Joint Model of Lung Function Decline and Mortality https://news.medxy.ai/zh/isold-score-and-vitreoretinal-lymphoma/Medxy AIzh2026-07-09T09:49:27-07:00ISOLD评分在玻璃体视网膜淋巴瘤临床诊断中的价值评估 https://news.medxy.ai/ja/isold-score-in-vitreoretinal-lymphoma/Medxy AIja2026-07-09T09:49:03-07:00臨床診療でみる硝子体網膜リンパ腫診断：ISOLDスコアの精度を検証する https://news.medxy.ai/vi/isold-score-for-vitreoretinal-lymphoma/Medxy AIvi2026-07-09T09:48:38-07:00Đánh giá thang điểm ISOLD trong chẩn đoán chính xác lymphoma võng mạc-thủy tinh thể trong thực hành lâm sàng https://news.medxy.ai/evaluating-the-isold-score-for-accurate-diagnosis-of-vitreoretinal-lymphoma-in-clinical-practice/Medxy AIen2026-07-09T09:47:13-07:00Evaluating the ISOLD Score for Accurate Diagnosis of Vitreoretinal Lymphoma in Clinical Practice https://news.medxy.ai/blood-pressure-assessment-in-ophthalmology-clinics-for-patients-with-diabetes/Medxy AIen2026-07-09T09:45:36-07:00Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis https://news.medxy.ai/zh/visual-field-testing-in-early-glaucoma-progression/Medxy AIzh2026-07-09T08:28:18-07:00早期青光眼进展监测中10-2视野检查的临床价值评估 https://news.medxy.ai/ja/visual-field-testing-in-early-glaucoma/Medxy AIja2026-07-09T08:27:55-07:00早期緑内障の進行検出における10-2視野検査の臨床的有用性を評価する https://news.medxy.ai/vi/visual-field-testing-in-early-glaucoma-progression-detection/Medxy AIvi2026-07-09T08:27:25-07:00Đánh giá giá trị lâm sàng của thử nghiệm thị trường thị giác 10-2 trong phát hiện sớm tiến triển glôcôm https://news.medxy.ai/evaluating-the-clinical-utility-of-10-2-visual-field-testing-in-early-glaucoma-progression-detection/Medxy AIen2026-07-09T08:25:50-07:00Evaluating the Clinical Utility of 10-2 Visual Field Testing in Early Glaucoma Progression Detection https://news.medxy.ai/zh/antireflux-diet-versus-medication-3/Medxy AIzh2026-07-08T21:50:24-07:00抗反流饮食与药物治疗之比较：咽喉反流病管理的新证据 https://news.medxy.ai/ja/antireflux-diet-versus-medication-2/Medxy AIja2026-07-08T21:50:08-07:00食事療法は薬物療法に勝るか？ 咽喉頭逆流症治療を比較検証 https://news.medxy.ai/vi/antireflux-diet-versus-medication/Medxy AIvi2026-07-08T21:49:50-07:00Chế độ ăn chống trào ngược hay thuốc điều trị: Phân tích so sánh trong kiểm soát bệnh trào ngược họng-thanh quản https://news.medxy.ai/antireflux-diet-versus-medication-a-comparative-analysis-in-laryngopharyngeal-reflux-disease-management/Medxy AIen2026-07-08T21:48:50-07:00Antireflux Diet Versus Medication: A Comparative Analysis in Laryngopharyngeal Reflux Disease Management https://news.medxy.ai/zh/vocal-fold-opening-position-in-vocal-atrophy/Medxy AIzh2026-07-08T21:44:52-07:00声带开放位置对年龄相关性声带萎缩弓形测量的影响：临床意义与未来方向 https://news.medxy.ai/ja/vocal-fold-opening-position-in-age-related-vocal-atrophy/Medxy AIja2026-07-08T21:44:36-07:00加齢性声帯萎縮における声帯開大位が弓状変形評価に与える影響：臨床的意義と今後の展望 https://news.medxy.ai/vi/vocal-fold-opening-position-on-bowing-in-age-related-vocal-atrophy/Medxy AIvi2026-07-08T21:44:15-07:00Ảnh hưởng của vị trí mở dây thanh đến các chỉ số độ lõm cong trong teo thanh quản do tuổi tác: ý nghĩa lâm sàng và định hướng tương lai https://news.medxy.ai/vocal-fold-opening-position-on-bowing-measures-in-age-related-vocal-atrophy/Medxy AIen2026-07-08T21:43:31-07:00Impact of Vocal Fold Opening Position on Bowing Measures in Age-Related Vocal Atrophy: Clinical Implications and Future Directions https://news.medxy.ai/zh/modified-frailty-index-on-liver-transplant/Medxy AIzh2026-07-08T21:23:31-07:00改良虚弱指数对肝移植结局的影响：一项多中心队列研究的启示 https://news.medxy.ai/ja/modified-frailty-index-on-liver-transplant-outcomes/Medxy AIja2026-07-08T21:23:13-07:00肝移植成績を左右する修正フレイル指標――多施設コホート研究から見えた臨床的示唆 https://news.medxy.ai/vi/impact-of-modified-frailty-index-on-liver-transplant-outcomes/Medxy AIvi2026-07-08T21:22:51-07:00Chỉ số suy yếu đã sửa đổi ảnh hưởng thế nào đến kết cục ghép gan? Bằng chứng từ một nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/impact-of-modified-frailty-index-on-liver-transplant-outcomes-insights-from-a-multicenter-cohort-study/Medxy AIen2026-07-08T21:21:56-07:00Impact of Modified Frailty Index on Liver Transplant Outcomes: Insights from a Multicenter Cohort Study https://news.medxy.ai/zh/sacrospinous-hysteropexy-with-mesh-or-uterovaginal-prolapse/Medxy AIzh2026-07-08T21:02:31-07:00子宫阴道脱垂治疗10年比较：带网片骶棘韧带子宫悬吊术与阴式子宫切除术的长期疗效与安全性 https://news.medxy.ai/ja/sacrospinous-hysteropexy-with-mesh-versus-vaginal-hysterectomy-for-uterovaginal-prolapse/Medxy AIja2026-07-08T21:02:14-07:00子宮腟脱に対するメッシュ併用仙棘靭帯子宮固定術と経腟子宮全摘術の10年比較成績：長期有効性と安全性 https://news.medxy.ai/vi/outcomes-of-sacrospinous-hysteropexy-with-mesh-versus-vaginal-hysterectomy-for-uterovaginal-prolapse-2/Medxy AIvi2026-07-08T21:01:53-07:00So sánh 10 năm giữa hysteropexy qua dây chằng gai hông có mesh và cắt tử cung đường âm đạo trong sa tử cung-âm đạo: Hiệu quả và an toàn lâu dài https://news.medxy.ai/outcomes-of-sacrospinous-hysteropexy-with-mesh-versus-vaginal-hysterectomy-for-uterovaginal-prolapse/Medxy AIen2026-07-08T21:01:06-07:00Ten-Year Comparative Outcomes of Sacrospinous Hysteropexy With Mesh Versus Vaginal Hysterectomy for Uterovaginal Prolapse: Long-Term Efficacy and Safety https://news.medxy.ai/zh/simultaneous-liver-kidney-transplantation/Medxy AIzh2026-07-08T15:37:37-07:00同步肝肾移植的新边界：借助机器灌注技术拓展DCD供者应用 https://news.medxy.ai/ja/horizon-of-simultaneous-liver-kidney-transplantation/Medxy AIja2026-07-08T15:37:22-07:00同時肝腎移植の新たな展望：機械灌流技術で広がるDCDドナー活用 https://news.medxy.ai/vi/expanding-the-horizon-of-simultaneous-liver-kidney-transplantation/Medxy AIvi2026-07-08T15:37:02-07:00Mở rộng chỉ định ghép gan-thận đồng thời: khai thác người hiến DCD với công nghệ tưới máu bằng máy https://news.medxy.ai/expanding-the-horizon-of-simultaneous-liver-kidney-transplantation-leveraging-dcd-donors-with-machine-perfusion-technologies/Medxy AIen2026-07-08T15:36:21-07:00Expanding the Horizon of Simultaneous Liver-Kidney Transplantation: Leveraging DCD Donors with Machine Perfusion Technologies https://news.medxy.ai/zh/sglt2-inhibitors-reduce-endometrial-cancer/Medxy AIzh2026-07-08T15:08:05-07:00SGLT2抑制剂联用孕激素：良性子宫疾病中降低子宫内膜癌风险的新证据 https://news.medxy.ai/ja/sglt2-inhibitors-reduce-endometrial-cancer-risk/Medxy AIja2026-07-08T15:07:50-07:00良性子宮疾患におけるSGLT2阻害薬の併用が子宮内膜がんリスクを低減：大規模実臨床研究からの示唆 https://news.medxy.ai/vi/sglt2-inhibitors-with-progestins-reduce-endometrial-cancer-risk/Medxy AIvi2026-07-08T15:07:33-07:00Thuốc ức chế SGLT2 dùng kèm progestin có thể làm giảm nguy cơ ung thư nội mạc tử cung ở bệnh lý tử cung lành tính: Góc nhìn từ một nghiên cứu thực tế quy mô lớn https://news.medxy.ai/adjunctive-sglt2-inhibitors-with-progestins-reduce-endometrial-cancer-risk/Medxy AIen2026-07-08T15:06:54-07:00Adjunctive SGLT2 Inhibitors with Progestins Reduce Endometrial Cancer Risk in Benign Uterine Conditions: Insights from a Large Real-World Study https://news.medxy.ai/labour-progression-differences-between-ivf-icsi-and-spontaneous-pregnancies-following-induction-insights-from-a-matched-cohort-study/Medxy AIen2026-07-08T15:05:06-07:00Labour Progression Differences Between IVF/ICSI and Spontaneous Pregnancies Following Induction: Insights from a Matched Cohort Study https://news.medxy.ai/zh/removal-of-urinary-catheters-after-urogynecologic-surgery/Medxy AIzh2026-07-08T15:04:17-07:00泌尿妇科手术后导尿管能否更早在家拔除？一项随机对照试验 https://news.medxy.ai/ja/early-home-removal-of-urinary-catheters-after-urogynecologic-surgery-rct/Medxy AIja2026-07-08T15:04:02-07:00婦人泌尿器科手術後の尿道カテーテル早期在宅抜去を検証：ランダム化比較試験 https://news.medxy.ai/vi/early-removal-of-urinary-catheters-after-urogynecologic-surgery/Medxy AIvi2026-07-08T15:03:45-07:00Đánh giá việc tháo ống thông tiểu sớm tại nhà sau phẫu thuật phụ khoa – tiết niệu: Thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/early-home-removal-of-urinary-catheters-after-urogynecologic-surgery/Medxy AIen2026-07-08T15:03:06-07:00Evaluating Early Home Removal of Urinary Catheters After Urogynecologic Surgery: A Randomized Controlled Trial https://news.medxy.ai/vi/postpartum-glucose-tolerance-test-results/Medxy AIvi2026-07-08T14:59:36-07:00Đánh giá kết quả nghiệm pháp dung nạp glucose hậu sản theo tiêu chuẩn và thời điểm: hàm ý đối với độ chính xác chẩn đoán và thực hành lâm sàng https://news.medxy.ai/evaluation-of-postpartum-glucose-tolerance-test-results-based-on-criteria-and-timing/Medxy AIen2026-07-08T14:58:45-07:00Evaluation of Postpartum Glucose Tolerance Test Results Based on Criteria and Timing: Implications for Diagnostic Accuracy and Clinical Practice https://news.medxy.ai/zh/klf9-nr4a1-p38-mapk-in-osa/Medxy AIzh2026-07-08T14:58:25-07:00揭示KLF9-NR4A1-p38 MAPK轴：阻塞性睡眠呼吸暂停中间歇性低氧关联MASLD的新机制 https://news.medxy.ai/ja/klf9-nr4a1-p38-mapk-axis-in-osa/Medxy AIja2026-07-08T14:58:10-07:00KLF9-NR4A1-p38 MAPK軸の解明：閉塞性睡眠時無呼吸における低酸素周期とMASLDをつなぐ新規機序 https://news.medxy.ai/vi/klf9-nr4a1-p38-mapk-in-obstructive-sleep-apnea/Medxy AIvi2026-07-08T14:57:54-07:00Giải mã trục KLF9-NR4A1-p38 MAPK: cơ chế mới liên kết thiếu oxy ngắt quãng với MASLD trong ngưng thở tắc nghẽn khi ngủ https://news.medxy.ai/klf9-nr4a1-p38-mapk-axis-in-obstructive-sleep-apnea/Medxy AIen2026-07-08T14:57:18-07:00Unraveling the KLF9-NR4A1-p38 MAPK Axis: A Novel Mechanism Linking Intermittent Hypoxia to MASLD in Obstructive Sleep Apnea https://news.medxy.ai/zh/smpd1-driven-sphingolipid-metabolism-in-pancreatic-ductal-adenocarcinoma/Medxy AIzh2026-07-08T14:52:57-07:00靶向SMPD1驱动的鞘脂代谢，阻断胰腺导管腺癌中的KRAS信号传导 https://news.medxy.ai/ja/smpd1-in-pancreatic-ductal-adenocarcinoma/Medxy AIja2026-07-08T14:52:44-07:00SMPD1依存性スフィンゴ脂質代謝を標的としてKRASシグナルを断つ：膵管腺癌における新たな治療戦略 https://news.medxy.ai/vi/smpd1-driven-sphingolipid-metabolism-to-disrupt-kras-signaling/Medxy AIvi2026-07-08T14:52:28-07:00Nhắm vào chuyển hóa sphingolipid do SMPD1 điều khiển để làm gián đoạn tín hiệu KRAS trong pancreatic ductal adenocarcinoma https://news.medxy.ai/targeting-smpd1-driven-sphingolipid-metabolism-to-disrupt-kras-signaling-in-pancreatic-ductal-adenocarcinoma/Medxy AIen2026-07-08T14:51:48-07:00Targeting SMPD1-Driven Sphingolipid Metabolism to Disrupt KRAS Signaling in Pancreatic Ductal Adenocarcinoma https://news.medxy.ai/zh/gut-feeling-to-brain-mapping-in-ibs/Medxy AIzh2026-07-08T14:50:14-07:00从“想排便”的感觉到脑影像：解析 IBS 中的排便急迫感 https://news.medxy.ai/ja/gut-feeling-to-brain-mapping/Medxy AIja2026-07-08T14:50:00-07:00腸の違和感を脳で読み解く：IBS における排便切迫感の神経基盤 https://news.medxy.ai/vi/from-gut-feeling-to-brain-mapping/Medxy AIvi2026-07-08T14:49:42-07:00Từ cảm nhận từ ruột đến bản đồ não: Giải mã cảm giác mót đi đại tiện trong IBS https://news.medxy.ai/from-gut-feeling-to-brain-mapping-decoding-defecation-urgency-in-ibs/Medxy AIen2026-07-08T14:49:00-07:00From Gut Feeling to Brain Mapping: Decoding Defecation Urgency in IBS https://news.medxy.ai/vi/endovascular-thrombectomy-in-ischemic-stroke/Medxy AIvi2026-07-08T14:45:04-07:00Vượt ra ngoài ASPECTS: Xác định giới hạn điều trị của lấy huyết khối nội mạch trong đột quỵ thiếu máu cục bộ lõi lớn https://news.medxy.ai/redefining-patient-selection-for-endovascular-thrombectomy-in-large-core-ischemic-stroke/Medxy AIen2026-07-08T14:44:30-07:00Redefining Patient Selection for Endovascular Thrombectomy in Large-Core Ischemic Stroke: The Role of Quantitative Volumetry Beyond ASPECTS https://news.medxy.ai/beyond-aspects-defining-the-therapeutic-limit-of-endovascular-thrombectomy-in-large-core-ischemic-stroke/Medxy AIen2026-07-08T14:44:20-07:00Beyond ASPECTS: Defining the Therapeutic Limit of Endovascular Thrombectomy in Large-Core Ischemic Stroke https://news.medxy.ai/zh/lrp4-associated-myasthenia-gravis-in-german/Medxy AIzh2026-07-08T14:41:22-07:00LRP4抗体相关重症肌无力：德国MG登记研究揭示独特临床表型与治疗挑战 https://news.medxy.ai/ja/lrp4-associated-myasthenia-gravis-2/Medxy AIja2026-07-08T14:41:06-07:00LRP4抗体関連重症筋無力症：ドイツMGレジストリが示した独立した臨床像と治療上の課題 https://news.medxy.ai/vi/lrp4-associated-myasthenia-gravis/Medxy AIvi2026-07-08T14:40:49-07:00Nhược cơ liên quan kháng thể LRP4: kiểu hình lâm sàng riêng biệt và thách thức điều trị trong Cơ sở đăng ký MG Đức https://news.medxy.ai/lrp4-antibody-associated-myasthenia-gravis/Medxy AIen2026-07-08T14:40:10-07:00LRP4 Antibody-Associated Myasthenia Gravis: Distinct Clinical Phenotype and Treatment Challenges in the German MG Registry https://news.medxy.ai/decoding-tofersens-cns-penetrance-and-efficacy-in-sod1-als-through-autopsy-tissue-analysis/Medxy AIen2026-07-08T14:36:48-07:00Decoding Tofersen’s CNS Penetrance and Efficacy in SOD1-ALS Through Autopsy Tissue Analysis https://news.medxy.ai/zh/levacetylleucine%e5%9c%a8%e5%85%b1%e6%b5%8e%e5%a4%b1%e8%b0%83-%e6%af%9b%e7%bb%86%e8%a1%80%e7%ae%a1%e6%89%a9%e5%bc%a0%e7%97%87%e6%b2%bb%e7%96%97%e4%b8%ad%e6%98%be%e7%a4%ba%e5%87%ba%e8%89%af%e5%a5%bd/Medxy AIzh2026-07-08T14:34:34-07:00Levacetylleucine在共济失调-毛细血管扩张症治疗中显示出良好安全性与疗效：Ⅲ期试验结果 https://news.medxy.ai/ja/levacetylleucine%e3%80%81a-t%e3%81%ab%e6%9c%89%e6%9c%9b%e3%81%aa%e5%ae%89%e5%85%a8%e6%80%a7%e3%83%bb%e6%9c%89%e5%8a%b9%e6%80%a7%e3%80%80%e7%ac%ac3%e7%9b%b8%e8%a9%a6%e9%a8%93%e3%81%a7%e7%a5%9e%e7%b5%8c/Medxy AIja2026-07-08T14:34:18-07:00Levacetylleucine、A-Tに有望な安全性・有効性　第3相試験で神経機能改善を確認 https://news.medxy.ai/vi/levacetylleucine-cho-thay-tinh-an-toan-va-hieu-qua-day-hua-hen-trong-dieu-tri-ataxia-telangiectasia-ket-qua-thu-nghiem-giai-doan-3/Medxy AIvi2026-07-08T14:33:59-07:00Levacetylleucine cho thấy tính an toàn và hiệu quả đầy hứa hẹn trong điều trị ataxia-telangiectasia: Kết quả thử nghiệm giai đoạn 3 https://news.medxy.ai/levacetylleucine-shows-promising-safety-and-efficacy-in-treating-ataxia-telangiectasia-phase-3-trial-findings/Medxy AIen2026-07-08T14:33:10-07:00Levacetylleucine Shows Promising Safety and Efficacy in Treating Ataxia-Telangiectasia: Phase 3 Trial Findings https://news.medxy.ai/zh/%e6%88%90%e4%ba%ba%e7%94%b2%e7%8a%b6%e8%85%ba%e6%bf%80%e7%b4%a0%ce%b1%e5%9e%8b%e6%8a%b5%e6%8a%97%ef%bc%88rth%ce%b1%ef%bc%89%e7%9a%84%e5%b7%a6%e7%94%b2%e7%8a%b6%e8%85%ba%e7%b4%a0%e6%b2%bb%e7%96%97/Medxy AIzh2026-07-08T14:27:38-07:00成人甲状腺激素α型抵抗（RTHα）的左甲状腺素治疗：临床疗效、安全性与代谢学新发现 https://news.medxy.ai/ja/%e6%88%90%e4%ba%ba%e3%81%ae%e7%94%b2%e7%8a%b6%e8%85%ba%e3%83%9b%e3%83%ab%e3%83%a2%e3%83%b3%ce%b1%e6%8a%b5%e6%8a%97%e7%97%87%ef%bc%88resistance-to-thyroid-hormone-alpha-rth%ce%b1%ef%bc%89%e3%81%ab/Medxy AIja2026-07-08T14:27:23-07:00成人の甲状腺ホルモンα抵抗症（Resistance to Thyroid Hormone Alpha, RTHα）に対するチロキシン治療：臨床効果・安全性・代謝学的知見 https://news.medxy.ai/vi/dieu-tri-thyroxine-o-nguoi-truong-thanh-khang-hormon-tuyen-giap-alpha-rth%ce%b1-hieu-qua-lam-sang-tinh-an-toan-va-nhung-goi-y-chuyen-hoa/Medxy AIvi2026-07-08T14:27:05-07:00Điều trị thyroxine ở người trưởng thành kháng hormon tuyến giáp alpha (RTHα): hiệu quả lâm sàng, tính an toàn và những gợi ý chuyển hóa https://news.medxy.ai/thyroxine-therapy-in-adult-resistance-to-thyroid-hormone-alpha-rth%ce%b1-clinical-efficacy-safety-and-metabolic-insights/Medxy AIen2026-07-08T14:26:19-07:00Thyroxine Therapy in Adult Resistance to Thyroid Hormone Alpha (RTHα): Clinical Efficacy, Safety, and Metabolic Insights https://news.medxy.ai/zh/gip-regulating-splanchnic-blood-flow-t2dm/Medxy AIzh2026-07-08T14:19:55-07:00揭示GIP在2型糖尿病餐后内脏血流调控中的作用 https://news.medxy.ai/ja/gip-regulating-postprandial-splanchnic-blood-flow-t2dm/Medxy AIja2026-07-08T14:19:40-07:002型糖尿病における食後内臓血流調節を担うGIPの役割を解明 https://news.medxy.ai/vi/gip-regulating-postprandial-splanchnic-blood-flow/Medxy AIvi2026-07-08T14:19:23-07:00Vai trò của GIP trong điều hòa lưu lượng máu tạng sau ăn ở đái tháo đường type 2 https://news.medxy.ai/gip-in-regulating-postprandial-splanchnic-blood-flow/Medxy AIen2026-07-08T14:18:45-07:00Unveiling the Role of GIP in Regulating Postprandial Splanchnic Blood Flow in Type 2 Diabetes https://news.medxy.ai/vi/paradigms-in-diagnosing-cushings-disease/Medxy AIvi2026-07-08T13:51:54-07:00Xu hướng mới trong chẩn đoán bệnh Cushing: Lấy mẫu xoang đá dưới hai bên có đang dần trở nên lỗi thời? https://news.medxy.ai/evolving-paradigms-in-diagnosing-cushings-disease/Medxy AIen2026-07-08T13:50:52-07:00Evolving Paradigms in Diagnosing Cushing’s Disease: Is Bilateral Inferior Petrosal Sinus Sampling Becoming Obsolete? https://news.medxy.ai/vi/precision-medicine-for-young-onset-diabetes/Medxy AIvi2026-07-08T13:15:54-07:00Y học chính xác giúp cải thiện quản lý đái tháo đường khởi phát sớm nhưng chưa giảm biến chứng: Góc nhìn từ thử nghiệm ngẫu nhiên PRISM https://news.medxy.ai/precision-medicine-enhances-managementin-young-onset-diabetes/Medxy AIen2026-07-08T13:14:52-07:00Precision Medicine Enhances Management but Not Complications in Young-Onset Diabetes: Insights from the PRISM Randomized Trial https://news.medxy.ai/ja/insulin-for-youth-with-td1m/Medxy AIja2026-07-08T13:11:16-07:00低資源環境の若年1型糖尿病におけるヒトインスリンとアナログインスリン：HumAn-1試験から見えたこと https://news.medxy.ai/vi/insulin-for-youth-with-type-1-diabetes/Medxy AIvi2026-07-08T13:10:50-07:00Insulin người hay insulin tương tự cho trẻ và thanh thiếu niên mắc đái tháo đường týp 1 ở bối cảnh nguồn lực hạn chế: góc nhìn từ thử nghiệm HumAn-1 và các bằng chứng bổ trợ https://news.medxy.ai/human-versus-analogue-insulin-for-youth-with-type-1-diabetes/Medxy AIen2026-07-08T13:09:40-07:00Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings: Insights from the HumAn-1 Trial and Complementary Evidence https://news.medxy.ai/obicetrapibs-impact-on-lipoproteina-in-high-cardiovascular-risk-patients-a-comprehensive-pooled-analysis/Medxy AIen2026-07-07T22:19:40-07:00Obicetrapib’s Impact on Lipoprotein(a) in High Cardiovascular Risk Patients: A Comprehensive Pooled Analysis https://news.medxy.ai/sirolimus-eluting-balloons-in-coronary-in-stent-restenosis/Medxy AIen2026-07-07T22:16:24-07:00Sirolimus-Eluting Balloons in Coronary In-Stent Restenosis: Comparative Efficacy Against Repeat DES and Balloon Angioplasty https://news.medxy.ai/adolescent-cardiorespiratory-fitness/Medxy AIen2026-07-07T22:13:21-07:00Adolescent Cardiorespiratory Fitness and the Trade-Off Between Atrial Fibrillation Risk and Cardiovascular Benefits: Evidence from a Nationwide Sibling-Controlled Cohort Study https://news.medxy.ai/zh/sept9-for-hepatocellular-carcinoma-in-cirrhotic-patients/Medxy AIzh2026-07-07T22:01:08-07:00循环甲基化 SEPT9：肝硬化患者肝细胞癌早检的新型生物标志物 https://news.medxy.ai/vi/sept9-hepatocellular-carcinoma-in-cirrhotic/Medxy AIvi2026-07-07T22:00:32-07:00SEPT9 metyl hóa lưu hành: dấu ấn sinh học mới cho phát hiện sớm ung thư biểu mô tế bào gan ở bệnh nhân xơ gan https://news.medxy.ai/sept9-for-early-detection-of-hepatocellular-carcinoma-in-cirrhotic-patients/Medxy AIen2026-07-07T21:59:08-07:00Circulating Methylated SEPT9 as a Novel Biomarker for Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients